Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors

Personalized cancer treatment depends on the accurate and timely detection of the patient tumor variants. LBx enables minimally invasive tumor mutation profiling. We report results of a pan-Canadian LBx program for patients with advanced solid tumors. Plasma samples were tested at Imagia Canexia Hea...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Anna Lapuk, Benjamin L. S. Furman, Pedro Feijao, Ebru Baran, Sonal Brahmbhatt, Betty Chan, Ka Mun Nip, Adrian Kense, Brenda Murphy, Ruth Miller, Vincent Funari, Alicja Parker, Melissa K. McConechy, Shaqil Kassam, Arif A. Awan, Bryan Lo, Daniel Breadner, Barry D. Stein, David G. Huntsman
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-12-01
Serija:	Current Oncology
Teme:	liquid biopsy NGS biomarkers precision oncology health economics
Online dostop:	https://www.mdpi.com/1718-7729/33/1/18
Oznake:	Označite Brez oznak, prvi označite!